GGrantIndex
← Search

ADVL0414, A PHASE I STUDY OF TEMOZOLOMIDE, ORAL IRINOTECAN, AND VINCRISTINE F

$7,322M01FY2007RRNIH

Baylor College Of Medicine, Houston TX

Investigators

Linked publications & trials

View original record on NIH RePORTER →